This polymorphism also was found to reduce the tumor suppressor effect of miR-1269a possibly by attenuating the expression level of miR-1269a in HCC cells and overexpression of target genes SPATS2L and LRP6, and promoted the susceptibility to HCC [29]. This evidence concerns the gene SPATS2L and hepatocellular carcinoma.